Summary

The ventilators market is projected to reach USD 3.10 billion by 2031 from USD 2.49 billion in 2026 at a CAGR of 4.4% during the forecast period.

Increasing respiratory illnesses like COPD and asthma are key drivers of the ventilators market. With growing air pollution levels, lifestyles, and aging populations, an increased number of these chronic ailments have resulted in more frequent and severe respiratory attacks. COPD and severe asthma patients frequently need respiratory support through acute exacerbation, increasing hospital and homecare demand for both invasive and non-invasive ventilators. Further, ongoing advancements in ventilator technology—safety, accuracy, and patient outcomes—prompt healthcare professionals to invest in newer respiratory support equipment. The increasing burden of respiratory illnesses is thus driving market growth.

The high-end ICU ventilators segment accounts for the largest share of the global ventilators market.
Premium ICU ventilators dominate the global ventilators market because they are crucial for treating life-threatening conditions in intensive care units. These advanced devices offer a wide range of ventilation modes, sophisticated monitoring systems, and enhanced safety features, all of which are essential for critically ill patients. As the global population ages and the incidence of complex respiratory diseases rises, healthcare facilities are increasingly investing in next-generation ICU solutions. Additionally, continuous innovations and stringent regulations from governing bodies support the adoption of these advanced devices, making them the preferred choice for life-critical situations where optimal patient outcomes are important.

Combined mode ventilation has the largest market share in the ventilators market.
Combined mode ventilators hold the largest market share in the ventilator segment because they offer the best features of both volume- and pressure-controlled ventilation. This allows clinicians to tailor respiratory support to meet the individual needs of each patient. These ventilators enable precise control over tidal volumes while ensuring that pressure remains within safe limits to prevent lung injury, making them a versatile solution suitable for a variety of clinical situations.

Additionally, the advanced monitoring systems and automated adjustments of these devices enhance convenience and improve patient outcomes. As a result, combined mode ventilators are highly sought after in intensive care units where critically ill patients require adaptable and flexible ventilation options. Moreover, ongoing technological innovations, increased investments in healthcare facilities, and a rise in respiratory illnesses have all contributed to the growing demand for combined mode ventilators in the market.
Europe holds the second-largest market share in the ventilators market.
Europe is the world's second-largest ventilators market, with its established healthcare infrastructure, heavy government spending, and stringent regulation that guarantees top-quality products. Extensive coverage of intensive care units and hospitals in Europe, combined with a high incidence of respiratory conditions and an aging population, ensures rising demand for invasive and non-invasive ventilators.
Europe benefits from a dynamic community of leading producers and continuous innovation, resulting in the development of advanced technologies that enhance patient outcomes. Coupled with progressive healthcare initiatives and comprehensive insurance coverage, Europe stands out as a significant market for ventilators globally, securing its position as the second-largest market shareholder.
A breakdown of the primary participants (supply-side) for the ventilators market referred to for this report is provided below:
・ By Company Type: Tier 1–25%, Tier 2–40%, and Tier 3–35%
・ By Designation: C-level–20%, Director Level–38%, and Others–40%
・ By Region: North America–37%, Europe–28%, Asia Pacific–26%, Latin America- 6%, and Middle East and Africa– 1% and GCC Countries– 2%
Prominent players in this market include Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), ResMed (US), Nihon Kohden Corporation (Japan), ZOLL Medical Corporation (US), Getinge AB (Sweden), Drägerwerk AG & Co. KGaA (Germany), ICU Medical, Inc. (US), Hamilton Medical (Switzerland), Löwenstein Medical SE & Co. KG (Germany), Fisher & Paykel Healthcare Limited (New Zealand), Skanray Technologies Ltd. (India), aXcent Medical GmbH (Germany), Metran Co., Ltd. (Japan), MAGNAMED (Brazil), Leistung Ingeniería SRL (Argentina), Breas Medical AB (Sweden), Airon Corporation (US), TRITON Electronic Systems Ltd. (Russia), Bio-Med Devices, Inc. (US), HEYER Medical AG (Germany), AgVa Healthcare (India), Biodesign Innovation Labs (India), NOCCARC Robotics Pvt. Ltd. (India), Umbulizer (India), Schiller Healthcare India Pvt. Ltd. (India), and AVI Healthcare (India).
Research Coverage:
The market study covers the ventilators market across various segments. It aims to estimate the market size and growth potential of this market across different segments by mobility, type, age group, interface, mode, care setting, and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.
Reasons to Buy the Report
This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their positions in the market.
This report provides insights on:
 Analysis of Market Dynamics: Drivers (Rise in respiratory diseases
Urbanization and rising pollution levels, Rising obesity due to sedentary lifestyles, Growing geriatric population worldwide, Increasing preference for home care settings, Rising number of preterm births, Outbreak of infectious respiratory diseases), restraints (Shortage of skilled medical workers, Excessive purchase of ventilators during COVID-19, Reimbursement concerns), opportunities (Cost-efficiency of home care services, Growth opportunities in emerging economies), and challenges (Low awareness and inadequate resources in emerging economies, Harmful effects of respiratory devices on neonates, Supply chain disruptions, Global demand fluctuations)
 Services/Innovations: Detailed insights on upcoming technologies, research & development activities, and new product launches in the ventilators market.
 Market Development: Comprehensive information on the lucrative emerging markets, components, demographics, care settings, and regions.
 Market Diversification: Exhaustive information about the product portfolios, growing geographies, recent developments, and investments in the ventilators market.
 Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of the leading players in the ventilators market like ResMed (US), Getinge AB (Sweden), Koninklijke Philips N.V. (Netherlands), Drägerwerk AG & CO. KGAA (Germany), and ICU Medical, Inc. (US).

ページTOPに戻る

Table of Contents

1 INTRODUCTION 26
1.1 STUDY OBJECTIVES 26
1.2 MARKET DEFINITION 26
1.3 STUDY SCOPE 27
1.3.1 MARKETS COVERED & REGIONS CONSIDERED 27
1.3.2 INCLUSIONS & EXCLUSIONS 28
1.4 YEARS CONSIDERED 28
1.5 CURRENCY USED 29
1.6 STAKEHOLDERS 29
1.7 LIMITATIONS 29
1.8 SUMMARY OF CHANGES 30
2 EXECUTIVE SUMMARY 31
2.1 KEY INSIGHTS & MARKET HIGHLIGHTS 31
2.2 KEY MARKET PARTICIPANTS: INSIGHTS & DEVELOPMENTS 33
2.3 DISRUPTIVE TRENDS SHAPING MARKET GROWTH 34
2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS 35
2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST 36
3 PREMIUM INSIGHTS 37
3.1 VENTILATORS MARKET OVERVIEW 37
3.2 ASIA PACIFIC: VENTILATORS MARKET, BY MOBILITY AND COUNTRY (2025) 38
3.3 VENTILATORS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 39
3.4 VENTILATORS MARKET: REGIONAL MIX 39
3.5 VENTILATORS MARKET: DEVELOPED VS. EMERGING ECONOMIES 40
4 MARKET OVERVIEW 41
4.1 INTRODUCTION 41
4.2 MARKET DYNAMICS 41
4.2.1 DRIVERS 42
4.2.1.1 Rise in respiratory diseases 42
4.2.1.1.1 Increasing incidence of COPD and asthma 42
4.2.1.1.2 Growing tobacco consumption 42
4.2.1.2 Urbanization and rising pollution levels 43
4.2.1.3 Rising obesity due to sedentary lifestyles 43
4.2.1.4 Growing geriatric population worldwide 44
4.2.1.5 Increasing preference for home care settings 44
4.2.1.6 Rising number of preterm births 45
4.2.1.7 Outbreak of infectious respiratory diseases 45
4.2.2 RESTRAINTS 46
4.2.2.1 Shortage of skilled medical workers 46
4.2.2.2 Excessive purchase of ventilators during COVID-19 46
4.2.2.3 Reimbursement concerns 46
4.2.3 OPPORTUNITIES 47
4.2.3.1 Cost-efficiency of home care services 47
4.2.3.2 Growth opportunities in emerging economies 47
4.2.4 CHALLENGES 48
4.2.4.1 Low awareness and inadequate resources in emerging economies 48
4.2.4.2 Harmful effects of respiratory devices on neonates 48
4.2.4.3 Supply chain disruptions 48
4.2.4.4 Global demand fluctuations 49
4.3 UNMET NEEDS & WHITE SPACES 49
4.3.1 UNMET NEEDS IN VENTILATORS MARKET 49
4.3.2 WHITE SPACE OPPORTUNITIES 50
4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES 50
4.4.1 INTERCONNECTED MARKETS 50
4.4.2 CROSS-SECTOR OPPORTUNITIES 51
4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 52
5 INDUSTRY TRENDS 53
5.1 PORTER’S FIVE FORCES ANALYSIS 53
5.1.1 THREAT OF NEW ENTRANTS 54
5.1.2 THREAT OF SUBSTITUTES 55
5.1.3 BARGAINING POWER OF SUPPLIERS 55
5.1.4 BARGAINING POWER OF BUYERS 55
5.1.5 INTENSITY OF COMPETITIVE RIVALRY 55
5.2 MACROECONOMIC OUTLOOK 56
5.2.1 INTRODUCTION 56
5.2.2 GDP TRENDS & FORECAST 56
5.2.3 TRENDS IN GLOBAL VENTILATORS INDUSTRY 58
5.2.4 TRENDS IN GLOBAL HEALTHCARE & CRITICAL CARE INDUSTRY 58
5.3 SUPPLY CHAIN ANALYSIS 58
5.4 VALUE CHAIN ANALYSIS 60
5.5 ECOSYSTEM ANALYSIS 62
5.6 PRICING ANALYSIS 63
5.6.1 INDICATIVE PRICING OF VENTILATORS, BY KEY PLAYER, 2025 63
5.6.2 AVERAGE SELLING PRICE TREND OF VENTILATORS, BY REGION, 2023–2025 63
5.7 TRADE ANALYSIS 64
5.7.1 IMPORT SCENARIO (HS CODE 9018) 65
5.7.2 EXPORT DATA (HS CODE 9018) 65
5.8 KEY CONFERENCES & EVENTS, 2026–2027 66
5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 67
5.10 INVESTMENT & FUNDING SCENARIO 68
5.11 CASE STUDY ANALYSIS 68
5.11.1 CASE STUDY 1: SCALING AI-ENABLED CRITICAL CARE VENTILATION 68
5.11.2 CASE STUDY2: EXPANDING HOME RESPIRATORY CARE THROUGH CONNECTED VENTILATION 69
5.11.3 CASE STUDY 3: ENHANCING ICU RESPIRATORY CARE WITH INTEGRATED VENTILATION 69
5.12 IMPACT OF 2025 US TARIFFS ON VENTILATORS MARKET 70
5.12.1 INTRODUCTION 70
5.12.2 KEY TARIFF RATES 71
5.12.3 PRICE IMPACT ANALYSIS 72
5.12.4 IMPACT ON COUNTRIES/REGIONS 72
5.12.4.1 North America 72
5.12.4.2 Europe 72
5.12.4.3 Asia Pacific 73
5.12.5 END-USE INDUSTRY IMPACT 73
6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS 74
6.1 KEY EMERGING TECHNOLOGIES 74
6.1.1 INTELLIGENT & CLOSED-LOOP VENTILATION SYSTEMS 74
6.2 COMPLEMENTARY TECHNOLOGIES 74
6.2.1 REMOTE MONITORING SYSTEMS 74
6.3 TECHNOLOGY/PRODUCT ROADMAP 75
6.3.1 SHORT-TERM (2025–2027) | FOUNDATION & EARLY COMMERCIALIZATION 75
6.3.2 1.16.2 MID-TERM (2027–2030) | EXPANSION & STANDARDIZATION 75
6.3.3 1.16.3 LONG-TERM (2030–2035+) | MASS COMMERCIALIZATION & DISRUPTION 76
6.4 PATENT ANALYSIS 76
6.4.1 INSIGHTS: JURISDICTION & TOP APPLICANT ANALYSIS 77
6.5 FUTURE APPLICATIONS 78
6.5.1 AI-ENABLED REMOTE VENTILATION MANAGEMENT & PREDICTIVE CARE 78
6.5.2 SMART RESPIRATORY CARE ECOSYSTEMS 79
6.5.3 ADVANCED VENTILATOR CONSUMABLES & LUNG-PROTECTIVE SOLUTIONS 79
6.6 IMPACT OF AI/GEN AI ON VENTILATORS MARKET 80
6.6.1 TOP USE CASES & MARKET POTENTIAL 80
6.6.2 CASE STUDIES OF AI IMPLEMENTATION IN VENTILATORS MARKET 80
6.6.3 INTERCONNECTED ADJACENT ECOSYSTEMS & IMPACT ON MARKET PLAYERS 81
6.6.4 CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN VENTILATORS MARKET 82
7 REGULATORY LANDSCAPE 83
7.1 REGIONAL REGULATIONS & COMPLIANCE 83
7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 84
7.1.2 INDUSTRY STANDARDS 85
8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 87
8.1 DECISION-MAKING PROCESS 87
8.2 BUYER STAKEHOLDERS & BUYING EVALUATION CRITERIA 87
8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 87
8.2.2 BUYING CRITERIA 88
8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES 89
8.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES 89
8.5 MARKET PROFITABILITY 90
8.5.1 REVENUE POTENTIAL 90
8.5.2 COST DYNAMICS 91
8.5.3 MARGIN OPPORTUNITIES IN KEY APPLICATIONS 91
9 VENTILATORS MARKET, BY MOBILITY 92
9.1 INTRODUCTION 93
9.2 INTENSIVE CARE VENTILATORS 93
9.2.1 HIGH-END ICU VENTILATORS 96
9.2.1.1 Rising healthcare expenditure and improving infrastructure in emerging economies to drive market 96
9.2.2 MID-END ICU VENTILATORS 98
9.2.2.1 Higher affordability and accessibility to drive market 98
9.2.3 BASIC ICU VENTILATORS 100
9.2.3.1 Growing use in ambulatory care centers to drive market 100
9.3 PORTABLE/TRANSPORTABLE VENTILATORS 101
9.3.1 INCREASING DEMAND FOR COMPACT DEVICES FOR MECHANICAL VENTILATION TO DRIVE MARKET 101
10 VENTILATORS MARKET, BY TYPE 104
10.1 INTRODUCTION 105
10.2 ADULT & PEDIATRIC VENTILATORS 105
10.2.1 GROWING GERIATRIC POPULATION TO DRIVE MARKET 105
10.3 NEONATAL & INFANT VENTILATORS 106
10.3.1 TECHNOLOGICAL ADVANCEMENTS IN NEONATAL MONITORS TO DRIVE MARKET 106
11 VENTILATORS MARKET, BY INTERFACE 108
11.1 INTRODUCTION 109
11.2 DUAL-CAPABILITY VENTILATION 109
11.2.1 RISING PREVALENCE OF COPD & ARDS TO DRIVE MARKET GROWTH 109
11.3 NON-INVASIVE VENTILATION 110
11.3.1 RELIABILITY OF MECHANICAL DESIGNS TO SUPPORT MARKET GROWTH 110
11.4 INVASIVE VENTILATION 111
11.4.1 RISING PREVALENCE OF RESPIRATORY DISEASES TO DRIVE MARKET 111
12 VENTILATORS MARKET, BY MODE 113
12.1 INTRODUCTION 114
12.2 COMBINED-MODE VENTILATORS 114
12.2.1 COMBINED BENEFITS OF VOLUME-TARGETED AND PRESSURE-TARGETED VENTILATORS TO DRIVE MARKET 114
12.3 VOLUME-MODE VENTILATORS 115
12.3.1 INCREASING DEMAND FOR ADVANCED RESPIRATORY SUPPORT SYSTEMS IN HEALTHCARE SETTINGS TO DRIVE MARKET 115
12.4 PRESSURE-MODE VENTILATORS 116
12.4.1 PRESET INSPIRATORY PRESSURE MAINTENANCE AND BETTER PATIENT COMFORT TO DRIVE MARKET 116
12.5 OTHER VENTILATOR MODES 118
13 VENTILATORS MARKET, BY CARE SETTING 120
13.1 INTRODUCTION 121
13.2 HOSPITALS & CLINICS 121
13.2.1 RISING DEMAND FOR VENTILATORS IN PRIVATE HOSPITALS TO DRIVE MARKET 121
13.3 AMBULATORY CARE CENTERS 122
13.3.1 INCREASING NUMBER OF OUTPATIENT VISITS TO DRIVE MARKET 122
13.4 EMERGENCY MEDICAL SERVICES 123
13.4.1 HIGH INCIDENCE OF TRAUMA INJURIES TO DRIVE MARKET 123
13.5 HOME CARE SETTINGS 124
13.5.1 EMERGENCE OF REMOTE PATIENT MONITORING DEVICES TO DRIVE MARKET 124
14 VENTILATORS MARKET, BY REGION 126
14.1 INTRODUCTION 127
14.2 NORTH AMERICA 127
14.2.1 US 131
14.2.1.1 High prevalence of COPD to drive the market 131
14.2.2 CANADA 133
14.2.2.1 Increasing incidence of asthma to drive market growth 133
14.3 EUROPE 135
14.3.1 GERMANY 138
14.3.1.1 Rising healthcare spending to increase demand for high-end ventilators 138
14.3.2 FRANCE 140
14.3.2.1 Highly advanced healthcare system to drive adoption of ventilators in hospitals 140
14.3.3 UK 143
14.3.3.1 Increasing healthcare expenditure to drive market growth 143
14.3.4 ITALY 145
14.3.4.1 High growth in geriatric population and subsequent rise in age-related respiratory diseases to drive market 145
14.3.5 SPAIN 148
14.3.5.1 High burden on state-run health insurance system and poor healthcare infrastructure to restrain market growth 148
14.3.6 NETHERLANDS 150
14.3.6.1 Rising prevalence of respiratory diseases to drive market 150
14.3.7 REST OF EUROPE 152
14.4 ASIA PACIFIC 154
14.4.1 JAPAN 158
14.4.1.1 Established healthcare system to increase adoption of respiratory care devices 158
14.4.2 CHINA 160
14.4.2.1 High prevalence of COPD and lung cancer to propel demand 160
14.4.3 INDIA 162
14.4.3.1 Rising focus of global players on Indian market to drive adoption of advanced ventilators 162
14.4.4 AUSTRALIA 165
14.4.4.1 High prevalence of chronic lung diseases to drive demand for ventilators 165
14.4.5 REST OF ASIA PACIFIC 167
14.5 LATIN AMERICA 169
14.5.1 BRAZIL 172
14.5.1.1 Healthcare infrastructure improvement to support market growth 172
14.5.2 MEXICO 174
14.5.2.1 Rising obesity rate to increase incidence of respiratory diseases 174
14.5.3 ARGENTINA 177
14.5.3.1 Incidence of severe acute respiratory infections to drive market 177
14.5.4 REST OF LATIN AMERICA 179
14.6 MIDDLE EAST & AFRICA 181
14.6.1 RISING HEALTHCARE SPENDING AND PRESENCE OF MEDICAL DEVICE MANUFACTURING COMPANIES TO DRIVE MARKET 181
14.7 GCC COUNTRIES 184
14.7.1 HIGHER DISPOSABLE INCOME AND INCREASED GOVERNMENT HEALTHCARE EXPENDITURE TO PROPEL MARKET GROWTH 184
15 COMPETITIVE LANDSCAPE 187
15.1 OVERVIEW 187
15.1.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN VENTILATORS MARKET 188
15.2 REVENUE ANALYSIS, 2021–2025 189
15.3 MARKET SHARE ANALYSIS, 2025 189
15.4 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 191
15.4.1 STARS 191
15.4.2 EMERGING LEADERS 191
15.4.3 PERVASIVE PLAYERS 191
15.4.4 PARTICIPANTS 192
15.4.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 192
15.4.5.1 Company footprint 193
15.4.5.2 Company footprint 194
15.4.5.3 Mobility footprint 195
15.4.5.4 Type footprint 196
15.4.5.5 Interface footprint 197
15.4.5.6 Mode footprint 198
15.5 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025 199
15.5.1 PROGRESSIVE COMPANIES 199
15.5.2 RESPONSIVE COMPANIES 199
15.5.3 DYNAMIC COMPANIES 199
15.5.4 STARTING BLOCKS 199
15.5.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025 201
15.5.5.1 Detailed list of key startups/SMEs 201
15.5.5.2 Competitive benchmarking of key startups/SMEs 202
15.6 R&D EXPENDITURE 202
15.7 COMPANY VALUATION & FINANCIAL METRICS 203
15.7.1 FINANCIAL METRICS 203
15.7.2 COMPANY VALUATION 203
15.8 BRAND/PRODUCT COMPARISON 204
15.9 COMPETITIVE SCENARIO 204
15.9.1 PRODUCT LAUNCHES 205
15.9.2 DEALS 206
15.9.3 OTHER DEVELOPMENTS 208
16 COMPANY PROFILES 210
16.1 KEY PLAYERS 210
16.1.1 DRÄGERWERK AG & CO. KGAA 210
16.1.1.1 Business overview 210
16.1.1.2 Products offered 211
16.1.1.3 Recent developments 212
16.1.1.3.1 Product launches 212
16.1.1.3.2 Deals 212
16.1.1.3.3 Other developments 213
16.1.1.4 MnM view 213
16.1.1.4.1 Key strengths 213
16.1.1.4.2 Strategic choices 213
16.1.1.4.3 Weaknesses & competitive threats 214
16.1.2 GETINGE AB 215
16.1.2.1 Business overview 215
16.1.2.2 Products offered 216
16.1.2.3 Recent developments 217
16.1.2.3.1 Product launches 217
16.1.2.3.2 Deals 217
16.1.2.3.3 Other developments 217
16.1.2.4 MnM view 218
16.1.2.4.1 Key strengths 218
16.1.2.4.2 Strategic choices 218
16.1.2.4.3 Weaknesses & competitive threats 218
16.1.3 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. 219
16.1.3.1 Business overview 219
16.1.3.2 Products offered 220
16.1.3.3 Recent developments 221
16.1.3.3.1 Product launches 221
16.1.3.3.2 Other developments 221
16.1.3.4 MnM view 222
16.1.3.4.1 Key strengths 222
16.1.3.4.2 Strategic choices 222
16.1.3.4.3 Weaknesses & competitive threats 222
16.1.4 ASAHI KASEI CORPORATION 223
16.1.4.1 Business overview 223
16.1.4.2 Products offered 224
16.1.4.3 Recent developments 225
16.1.4.3.1 Deals 225
16.1.5 RESMED INC. 226
16.1.5.1 Business overview 226
16.1.5.2 Products offered 227
16.1.5.3 Recent developments 228
16.1.5.3.1 Product launches 228
16.1.5.3.2 Deals 228
16.1.5.3.3 Other developments 228
16.1.5.4 MnM view 229
16.1.5.4.1 Key strengths 229
16.1.5.4.2 Strategic choices 229
16.1.5.4.3 Weaknesses & competitive threats 229
16.1.6 KONINKLIJKE PHILIPS N.V. 230
16.1.6.1 Business overview 230
16.1.6.2 Products offered 231
16.1.6.3 Recent developments 232
16.1.6.3.1 Other developments 232
16.1.6.4 MnM view 232
16.1.6.4.1 Key strengths 232
16.1.6.4.2 Strategic choices 232
16.1.6.4.3 Weaknesses & competitive threats 233
16.1.7 ICU MEDICAL INC. 234
16.1.7.1 Business overview 234
16.1.7.2 Products offered 235
16.1.7.3 Recent developments 236
16.1.7.3.1 Deals 236
16.1.7.4 MnM view 236
16.1.7.4.1 Key strengths 236
16.1.7.4.2 Strategic choices 236
16.1.7.4.3 Weaknesses & competitive threats 237
16.1.8 AIR LIQUIDE 238
16.1.8.1 Business overview 238
16.1.8.2 Products offered 239
16.1.8.3 MnM view 240
16.1.8.3.1 Key strengths 240
16.1.8.3.2 Strategic choices 240
16.1.8.3.3 Weaknesses & competitive threats 241
16.1.9 FLEXICARE (GROUP) LIMITED 242
16.1.9.1 Business overview 242
16.1.9.2 Products offered 243
16.1.9.3 Recent developments 243
16.1.9.3.1 Deals 243
16.1.10 NIHON KOHDEN CORPORATION 244
16.1.10.1 Business overview 244
16.1.10.2 Products offered 245
16.1.10.3 Recent developments 245
16.1.10.3.1 Product launches 245
16.1.10.4 MnM view 245
16.1.10.4.1 Key strengths 245
16.1.10.4.2 Strategic choices 246
16.1.10.4.3 Weaknesses & competitive threats 246
16.1.11 GE HEALTHCARE 247
16.1.11.1 Business overview 247
16.1.11.2 Products offered 248
16.1.11.3 MnM view 248
16.1.11.3.1 Key strengths 248
16.1.11.3.2 Strategic choices 249
16.1.11.3.3 Weaknesses & competitive threats 249
16.1.12 HAMILTON MEDICAL 250
16.1.12.1 Business overview 250
16.1.12.2 Products offered 250
16.1.12.3 Recent developments 250
16.1.12.3.1 Product upgrades 250
16.1.12.3.2 Deals 251
16.1.12.3.3 Other developments 251
16.1.12.4 MnM view 252
16.1.12.4.1 Key strengths 252
16.1.12.4.2 Strategic choices 252
16.1.12.4.3 Weaknesses & competitive threats 252
16.1.13 LÖWENSTEIN MEDICAL TECHNOLOGY GMBH & CO. KG 253
16.1.13.1 Business overview 253
16.1.13.2 Products offered 253
16.1.13.3 MnM view 255
16.1.13.3.1 Key strengths 255
16.1.13.3.2 Strategic choices 255
16.1.13.3.3 Weaknesses & competitive threats 255
16.2 OTHER PLAYERS 256
16.2.1 SKANRAY TECHNOLOGIES, LTD. 256
16.2.2 METRAN CO., LTD. 257
16.2.3 MAGNAMED 257
16.2.4 LEISTUNG INGENIERÍA SRL 258
16.2.5 AIRON CORPORATION 258
16.2.6 TRITON ELECTRONIC SYSTEMS LTD. 259
16.2.7 BIO-MED DEVICES, INC. 259
16.2.8 HEYER MEDICAL AG 260
16.2.9 AGVA HEALTHCARE 260
16.2.10 SCHILLER AG 261
16.2.11 AVI HEALTHCARE LIMITED 262
16.2.12 MAGNAMEDIA B.V. 263
16.2.13 BREAS MEDICAL AB 264
16.2.14 BEIJING AEONMED CO., LTD 265
16.2.15 SHENZHEN COMEN MEDICAL INSTRUMENTS CO., LTD 266
16.2.16 REACT HEALTH 267
16.2.17 MICOMME MEDICAL TECHNOLOGY DEVELOPMENT CO., LTD 268
16.2.18 CHIRANA MEDICAL, A.S. 269
17 RESEARCH METHODOLOGY 270
17.1 RESEARCH DATA 270
17.1.1 SECONDARY RESEARCH 271
17.1.2 PRIMARY RESEARCH 272
17.2 MARKET SIZE ESTIMATION 276
17.3 MARKET BREAKDOWN & DATA TRIANGULATION 282
17.4 RESEARCH ASSUMPTIONS 283
17.5 RESEARCH LIMITATIONS 284
17.5.1 SCOPE-RELATED LIMITATIONS 284
17.5.2 METHODOLOGY-RELATED LIMITATIONS 284
17.6 RISK ASSESSMENT 284
18 APPENDIX 285
18.1 DISCUSSION GUIDE 285
18.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 290
18.3 CUSTOMIZATION OPTIONS 292
18.4 RELATED REPORTS 292
18.5 AUTHOR DETAILS 293

ページTOPに戻る

List of Tables/Graphs

TABLE 1 STANDARD CURRENCY CONVERSION RATES (USD) 29.
TABLE 2 DISORDERS AND DEATHS CAUSED BY SMOKING, 2024 42.
TABLE 3 VENTILATORS MARKET: PORTER’S FIVE FORCES ANALYSIS 53.
TABLE 4 GDP PERCENTAGE CHANGE, BY KEY COUNTRY, 2021–2030 56.
TABLE 5 INDICATIVE PRICING OF VENTILATORS, BY KEY PLAYER, 2025 (USD) 63.
TABLE 6 AVERAGE SELLING PRICE TREND OF HIGH-END VENTILATORS, BY REGION, 2023–2025 (USD) 64.
TABLE 7 IMPORT DATA FOR VENTILATOR PRODUCTS UNDER HS CODE 9018, BY COUNTRY, 2021–2025 (USD THOUSAND) 65.
TABLE 8 EXPORT DATA FOR VENTILATOR PRODUCTS UNDER HS CODE 9018, BY COUNTRY, 2021–2025 (USD THOUSAND) 66.
TABLE 9 VENTILATORS MARKET: DETAILED LIST OF KEY CONFERENCES & EVENTS (2026–2027) 66.
TABLE 10 US-ADJUSTED RECIPROCAL TARIFF RATES “RECIPROCAL TARIFF, ADJUSTED" FOR THE TOP 20 TRADE PARTNERS 71.
TABLE 11 KEY PRODUCT-RELATED TARIFF EFFECTIVE FOR VENTILATORS 71.
TABLE 12 VENTILATORS MARKET: CASE STUDIES RELATED TO AI IMPLEMENTATION 80.
TABLE 13 INTERCONNECTED ADJACENT ECOSYSTEMS & IMPACT ON MARKET PLAYERS 81.
TABLE 14 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 84.
TABLE 15 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 84.
TABLE 16 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 84.
TABLE 17 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 85.
TABLE 18 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 85.
TABLE 19 GLOBAL STANDARDS IN VENTILATORS MARKET 86.
TABLE 20 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR VENTILATORS 88.
TABLE 21 KEY BUYING CRITERIA FOR VENTILATORS 89.
TABLE 22 VENTILATORS MARKET: UNMET NEEDS/END-USER EXPECTATIONS 89.
TABLE 23 VENTILATORS MARKET, BY MOBILITY, 2024–2031 (USD MILLION) 93.
TABLE 24 INTENSIVE CARE VENTILATORS: KEY PRODUCTS 93.
TABLE 25 INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 94.
TABLE 26 INTENSIVE CARE VENTILATORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 95.
TABLE 27 INTENSIVE CARE VENTILATORS MARKET, BY REGION, 2024–2031 (THOUSAND UNITS) 95.
TABLE 28 HIGH-END ICU VENTILATORS: KEY PRODUCTS 96.
TABLE 29 HIGH-END ICU VENTILATORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 97.
TABLE 30 HIGH-END ICU VENTILATORS MARKET, BY REGION, 2024–2031 (THOUSAND UNITS) 97.
TABLE 31 MID-END ICU VENTILATORS: KEY PRODUCTS 98.
TABLE 32 MID-END ICU VENTILATORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 99.
TABLE 33 MID-END ICU VENTILATORS MARKET, BY REGION, 2024–2031 (THOUSAND UNITS) 99.
TABLE 34 BASIC ICU VENTILATORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 100.
TABLE 35 BASIC ICU VENTILATORS MARKET, BY REGION, 2024–2031 (THOUSAND UNITS) 101.
TABLE 36 PORTABLE/TRANSPORTABLE VENTILATORS: KEY PRODUCTS 102.
TABLE 37 PORTABLE/TRANSPORTABLE VENTILATORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 102.
TABLE 38 PORTABLE/TRANSPORTABLE VENTILATORS MARKET, BY REGION, 2024–2031 (THOUSAND UNITS) 103.
TABLE 39 VENTILATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 105.
TABLE 40 ADULT & PEDIATRIC VENTILATORS: KEY PRODUCTS 105.
TABLE 41 ADULT & PEDIATRIC VENTILATORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 106.
TABLE 42 NEONATAL & INFANT VENTILATORS: KEY PRODUCTS 107.
TABLE 43 NEONATAL & INFANT VENTILATORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 107.
TABLE 44 VENTILATORS MARKET, BY INTERFACE, 2024–2031 (USD MILLION) 109.
TABLE 45 DUAL-CAPABILITY VENTILATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 110.
TABLE 46 NON-INVASIVE VENTILATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 111.
TABLE 47 INVASIVE VENTILATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 112.
TABLE 48 VENTILATORS MARKET, BY MODE, 2024–2031 (USD MILLION) 114.
TABLE 49 COMBINED-MODE VENTILATORS: KEY PRODUCTS 114.
TABLE 50 COMBINED-MODE VENTILATORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 115.
TABLE 51 VOLUME-MODE VENTILATORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 116.
TABLE 52 PRESSURE-MODE VENTILATORS: KEY PRODUCTS 117.
TABLE 53 PRESSURE-MODE VENTILATORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 117.
TABLE 54 OTHER VENTILATOR MODES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 119.
TABLE 55 VENTILATORS MARKET, BY CARE SETTING, 2024–2031 (USD MILLION) 121.
TABLE 56 VENTILATORS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2024–2031 (USD MILLION) 122.
TABLE 57 VENTILATORS MARKET FOR AMBULATORY CARE CENTERS, BY COUNTRY, 2024–2031 (USD MILLION) 123.
TABLE 58 VENTILATORS MARKET FOR EMERGENCY MEDICAL SERVICES, BY COUNTRY, 2024–2031 (USD MILLION) 124.
TABLE 59 VENTILATORS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2024–2031 (USD MILLION) 125.
TABLE 60 VENTILATORS MARKET, BY REGION, 2024–2031 (USD MILLION) 127.
TABLE 61 NORTH AMERICA: VENTILATORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 128.
TABLE 62 NORTH AMERICA: VENTILATORS MARKET, BY MOBILITY, 2024–2031 (USD MILLION) 129.
TABLE 63 NORTH AMERICA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 129.
TABLE 64 NORTH AMERICA: VENTILATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 129.
TABLE 65 NORTH AMERICA: VENTILATORS MARKET, BY INTERFACE, 2024–2031 (USD MILLION) 130.
TABLE 66 NORTH AMERICA: VENTILATORS MARKET, BY MODE, 2024–2031 (USD MILLION) 130.
TABLE 67 NORTH AMERICA: VENTILATORS MARKET, BY CARE SETTING, 2024–2031 (USD MILLION) 130.
TABLE 68 US: VENTILATORS MARKET, BY MOBILITY, 2024–2031 (USD MILLION) 131.
TABLE 69 US: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 131.
TABLE 70 US: VENTILATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 132.
TABLE 71 US: VENTILATORS MARKET, BY INTERFACE, 2024–2031 (USD MILLION) 132.
TABLE 72 US: VENTILATORS MARKET, BY MODE, 2024–2031 (USD MILLION) 132.
TABLE 73 US: VENTILATORS MARKET, BY CARE SETTING, 2024–2031 (USD MILLION) 133.
TABLE 74 CANADA: VENTILATORS MARKET, BY MOBILITY, 2024–2031 (USD MILLION) 133.
TABLE 75 CANADA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 134.
TABLE 76 CANADA: VENTILATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 134.
TABLE 77 CANADA: VENTILATORS MARKET, BY INTERFACE, 2024–2031 (USD MILLION) 134.
TABLE 78 CANADA: VENTILATORS MARKET, BY MODE, 2024–2031 (USD MILLION) 135.
TABLE 79 CANADA: VENTILATORS MARKET, BY CARE SETTING, 2024–2031 (USD MILLION) 135.
TABLE 80 EUROPE: VENTILATORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 136.
TABLE 81 EUROPE: VENTILATORS MARKET, BY MOBILITY, 2024–2031 (USD MILLION) 136.
TABLE 82 EUROPE: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 136.
TABLE 83 EUROPE: VENTILATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 137.
TABLE 84 EUROPE: VENTILATORS MARKET, BY INTERFACE, 2024–2031 (USD MILLION) 137.
TABLE 85 EUROPE: VENTILATORS MARKET, BY MODE, 2024–2031 (USD MILLION) 137.
TABLE 86 EUROPE: VENTILATORS MARKET, BY CARE SETTING, 2024–2031 (USD MILLION) 138.
TABLE 87 GERMANY: VENTILATORS MARKET, BY MOBILITY, 2024–2031 (USD MILLION) 138.
TABLE 88 GERMANY: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 139.
TABLE 89 GERMANY: VENTILATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 139.
TABLE 90 GERMANY: VENTILATORS MARKET, BY INTERFACE, 2024–2031 (USD MILLION) 139.
TABLE 91 GERMANY: VENTILATORS MARKET, BY MODE, 2024–2031 (USD MILLION) 140.
TABLE 92 GERMANY: VENTILATORS MARKET, BY CARE SETTING, 2024–2031 (USD MILLION) 140.
TABLE 93 FRANCE: VENTILATORS MARKET, BY MOBILITY, 2024–2031 (USD MILLION) 141.
TABLE 94 FRANCE: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 141.
TABLE 95 FRANCE: VENTILATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 141.
TABLE 96 FRANCE: VENTILATORS MARKET, BY INTERFACE, 2024–2031 (USD MILLION) 142.
TABLE 97 FRANCE: VENTILATORS MARKET, BY MODE, 2024–2031 (USD MILLION) 142.
TABLE 98 FRANCE: VENTILATORS MARKET, BY CARE SETTING, 2024–2031 (USD MILLION) 142.
TABLE 99 UK: VENTILATORS MARKET, BY MOBILITY, 2024–2031 (USD MILLION) 143.
TABLE 100 UK: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 144.
TABLE 101 UK: VENTILATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 144.
TABLE 102 UK: VENTILATORS MARKET, BY INTERFACE, 2024–2031 (USD MILLION) 144.
TABLE 103 UK: VENTILATORS MARKET, BY MODE, 2024–2031 (USD MILLION) 145.
TABLE 104 UK: VENTILATORS MARKET, BY CARE SETTING, 2024–2031 (USD MILLION) 145.
TABLE 105 ITALY: VENTILATORS MARKET, BY MOBILITY, 2024–2031 (USD MILLION) 146.
TABLE 106 ITALY: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 146.
TABLE 107 ITALY: VENTILATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 146.
TABLE 108 ITALY: VENTILATORS MARKET, BY INTERFACE, 2024–2031 (USD MILLION) 147.
TABLE 109 ITALY: VENTILATORS MARKET, BY MODE, 2024–2031 (USD MILLION) 147.
TABLE 110 ITALY: VENTILATORS MARKET, BY CARE SETTING, 2024–2031 (USD MILLION) 147.
TABLE 111 SPAIN: VENTILATORS MARKET, BY MOBILITY, 2024–2031 (USD MILLION) 148.
TABLE 112 SPAIN: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 148.
TABLE 113 SPAIN: VENTILATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 148.
TABLE 114 SPAIN: VENTILATORS MARKET, BY INTERFACE, 2024–2031 (USD MILLION) 149.
TABLE 115 SPAIN: VENTILATORS MARKET, BY MODE, 2024–2031 (USD MILLION) 149.
TABLE 116 SPAIN: VENTILATORS MARKET, BY CARE SETTING, 2024–2031 (USD MILLION) 149.
TABLE 117 NETHERLANDS: VENTILATORS MARKET, BY MOBILITY, 2024–2031 (USD MILLION) 150.
TABLE 118 NETHERLANDS: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 150.
TABLE 119 NETHERLANDS: VENTILATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 150.
TABLE 120 NETHERLANDS: VENTILATORS MARKET, BY INTERFACE, 2024–2031 (USD MILLION) 151.
TABLE 121 NETHERLANDS: VENTILATORS MARKET, BY MODE, 2024–2031 (USD MILLION) 151.
TABLE 122 NETHERLANDS: VENTILATORS MARKET, BY CARE SETTING, 2024–2031 (USD MILLION) 151.
TABLE 123 REST OF EUROPE: VENTILATORS MARKET, BY MOBILITY, 2024–2031 (USD MILLION) 152.
TABLE 124 REST OF EUROPE: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 152.
TABLE 125 REST OF EUROPE: VENTILATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 153.
TABLE 126 REST OF EUROPE: VENTILATORS MARKET, BY INTERFACE, 2024–2031 (USD MILLION) 153.
TABLE 127 REST OF EUROPE: VENTILATORS MARKET, BY MODE, 2024–2031 (USD MILLION) 153.
TABLE 128 REST OF EUROPE: VENTILATORS MARKET, BY CARE SETTING, 2024–2031 (USD MILLION) 154.
TABLE 129 ASIA PACIFIC: VENTILATORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 155.
TABLE 130 ASIA PACIFIC: VENTILATORS MARKET, BY MOBILITY, 2024–2031 (USD MILLION) 156.
TABLE 131 ASIA PACIFIC: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 156.
TABLE 132 ASIA PACIFIC: VENTILATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 156.
TABLE 133 ASIA PACIFIC: VENTILATORS MARKET, BY INTERFACE, 2024–2031 (USD MILLION) 157.
TABLE 134 ASIA PACIFIC: VENTILATORS MARKET, BY MODE, 2024–2031 (USD MILLION) 157.
TABLE 135 ASIA PACIFIC: VENTILATORS MARKET, BY CARE SETTING, 2024–2031 (USD MILLION) 157.
TABLE 136 JAPAN: VENTILATORS MARKET, BY MOBILITY, 2024–2031 (USD MILLION) 158.
TABLE 137 JAPAN: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 158.
TABLE 138 JAPAN: VENTILATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 159.
TABLE 139 JAPAN: VENTILATORS MARKET, BY INTERFACE, 2024–2031 (USD MILLION) 159.
TABLE 140 JAPAN: VENTILATORS MARKET, BY MODE, 2024–2031 (USD MILLION) 159.
TABLE 141 JAPAN: VENTILATORS MARKET, BY CARE SETTING, 2024–2031 (USD MILLION) 160.
TABLE 142 CHINA: VENTILATORS MARKET, BY MOBILITY, 2024–2031 (USD MILLION) 160.
TABLE 143 CHINA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 161.
TABLE 144 CHINA: VENTILATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 161.
TABLE 145 CHINA: VENTILATORS MARKET, BY INTERFACE, 2024–2031 (USD MILLION) 161.
TABLE 146 CHINA: VENTILATORS MARKET, BY MODE, 2024–2031 (USD MILLION). 162.
TABLE 147 CHINA: VENTILATORS MARKET, BY CARE SETTING, 2024–2031 (USD MILLION) 162.
TABLE 148 INDIA: VENTILATORS MARKET, BY MOBILITY, 2024–2031 (USD MILLION) 163.
TABLE 149 INDIA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 163.
TABLE 150 INDIA: VENTILATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 163.
TABLE 151 INDIA: VENTILATORS MARKET, BY INTERFACE, 2024–2031 (USD MILLION) 164.
TABLE 152 INDIA: VENTILATORS MARKET, BY MODE, 2024–2031 (USD MILLION) 164.
TABLE 153 INDIA: VENTILATORS MARKET, BY CARE SETTING, 2024–2031 (USD MILLION) 164.
TABLE 154 AUSTRALIA: VENTILATORS MARKET, BY MOBILITY, 2024–2031 (USD MILLION) 165.
TABLE 155 AUSTRALIA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 165.
TABLE 156 AUSTRALIA: VENTILATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 166.
TABLE 157 AUSTRALIA: VENTILATORS MARKET, BY INTERFACE, 2024–2031 (USD MILLION) 166.
TABLE 158 AUSTRALIA: VENTILATORS MARKET, BY MODE, 2024–2031 (USD MILLION) 166.
TABLE 159 AUSTRALIA: VENTILATORS MARKET, BY CARE SETTING, 2024–2031 (USD MILLION) 167.
TABLE 160 REST OF ASIA PACIFIC: VENTILATORS MARKET, BY MOBILITY, 2024–2031 (USD MILLION) 167.
TABLE 161 REST OF ASIA PACIFIC: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 168.
TABLE 162 REST OF ASIA PACIFIC: VENTILATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 168.
TABLE 163 REST OF ASIA PACIFIC: VENTILATORS MARKET, BY INTERFACE, 2024–2031 (USD MILLION) 168.
TABLE 164 REST OF ASIA PACIFIC: VENTILATORS MARKET, BY MODE, 2024–2031 (USD MILLION) 169.
TABLE 165 REST OF ASIA PACIFIC: VENTILATORS MARKET, BY CARE SETTING, 2024–2031 (USD MILLION) 169.
TABLE 166 LATIN AMERICA: VENTILATORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 170.
TABLE 167 LATIN AMERICA: VENTILATORS MARKET, BY MOBILITY, 2024–2031 (USD MILLION) 170.
TABLE 168 LATIN AMERICA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 170.
TABLE 169 LATIN AMERICA: VENTILATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 171.
TABLE 170 LATIN AMERICA: VENTILATORS MARKET, BY INTERFACE, 2024–2031 (USD MILLION) 171.
TABLE 171 LATIN AMERICA: VENTILATORS MARKET, BY MODE, 2024–2031 (USD MILLION) 171.
TABLE 172 LATIN AMERICA: VENTILATORS MARKET, BY CARE SETTING, 2024–2031 (USD MILLION) 172.
TABLE 173 BRAZIL: VENTILATORS MARKET, BY MOBILITY, 2024–2031 (USD MILLION) 172.
TABLE 174 BRAZIL: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 173.
TABLE 175 BRAZIL: VENTILATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 173.
TABLE 176 BRAZIL: VENTILATORS MARKET, BY INTERFACE, 2024–2031 (USD MILLION) 173.
TABLE 177 BRAZIL: VENTILATORS MARKET, BY MODE, 2024–2031 (USD MILLION) 174.
TABLE 178 BRAZIL: VENTILATORS MARKET, BY CARE SETTING, 2024–2031 (USD MILLION) 174.
TABLE 179 MEXICO: VENTILATORS MARKET, BY MOBILITY, 2024–2031 (USD MILLION) 175.
TABLE 180 MEXICO: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 175.
TABLE 181 MEXICO: VENTILATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 175.
TABLE 182 MEXICO: VENTILATORS MARKET, BY INTERFACE, 2024–2031 (USD MILLION) 176.
TABLE 183 MEXICO: VENTILATORS MARKET, BY MODE, 2024–2031 (USD MILLION) 176.
TABLE 184 MEXICO: VENTILATORS MARKET, BY CARE SETTING, 2024–2031 (USD MILLION) 176.
TABLE 185 ARGENTINA: VENTILATORS MARKET, BY MOBILITY, 2024–2031 (USD MILLION) 177.
TABLE 186 ARGENTINA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 177.
TABLE 187 ARGENTINA: VENTILATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 178.
TABLE 188 ARGENTINA: VENTILATORS MARKET, BY INTERFACE, 2024–2031 (USD MILLION) 178.
TABLE 189 ARGENTINA: VENTILATORS MARKET, BY MODE, 2024–2031 (USD MILLION) 178.
TABLE 190 ARGENTINA: VENTILATORS MARKET, BY CARE SETTING, 2024–2031 (USD MILLION) 179.
TABLE 191 REST OF LATIN AMERICA: VENTILATORS MARKET, BY MOBILITY, 2024–2031 (USD MILLION) 179.
TABLE 192 REST OF LATIN AMERICA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 180.
TABLE 193 REST OF LATIN AMERICA: VENTILATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 180.
TABLE 194 REST OF LATIN AMERICA: VENTILATORS MARKET, BY INTERFACE, 2024–2031 (USD MILLION) 180.
TABLE 195 REST OF LATIN AMERICA: VENTILATORS MARKET, BY MODE, 2024–2031 (USD MILLION) 181.
TABLE 196 REST OF LATIN AMERICA: VENTILATORS MARKET, BY CARE SETTING, 2024–2031 (USD MILLION) 181.
TABLE 197 MIDDLE EAST & AFRICA: VENTILATORS MARKET, BY MOBILITY, 2024–2031 (USD MILLION) 182.
TABLE 198 MIDDLE EAST & AFRICA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 182.
TABLE 199 MIDDLE EAST & AFRICA: VENTILATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 182.
TABLE 200 MIDDLE EAST & AFRICA: VENTILATORS MARKET, BY INTERFACE, 2024–2031 (USD MILLION) 183.
TABLE 201 MIDDLE EAST & AFRICA: VENTILATORS MARKET, BY MODE, 2024–2031 (USD MILLION) 183.
TABLE 202 MIDDLE EAST & AFRICA: VENTILATORS MARKET, BY CARE SETTING, 2024–2031 (USD MILLION) 183.
TABLE 203 GCC COUNTRIES: VENTILATORS MARKET, BY MOBILITY, 2024–2031 (USD MILLION) 184.
TABLE 204 GCC COUNTRIES: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 185.
TABLE 205 GCC COUNTRIES: VENTILATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 185.
TABLE 206 GCC COUNTRIES: VENTILATORS MARKET, BY INTERFACE, 2024–2031 (USD MILLION) 185.
TABLE 207 GCC COUNTRIES: VENTILATORS MARKET, BY MODE, 2024–2031 (USD MILLION) 186.
TABLE 208 GCC COUNTRIES: VENTILATORS MARKET, BY CARE SETTING, 2024–2031 (USD MILLION) 186.
TABLE 209 VENTILATORS MARKET: DEGREE OF COMPETITION 190.
TABLE 210 VENTILATORS MARKET: REGION FOOTPRINT 194.
TABLE 211 VENTILATORS MARKET: MOBILITY FOOTPRINT 195.
TABLE 212 VENTILATORS MARKET: TYPE FOOTPRINT 196.
TABLE 213 VENTILATORS MARKET: INTERFACE FOOTPRINT 197.
TABLE 214 VENTILATORS MARKET: MODE FOOTPRINT 198.
TABLE 215 VENTILATORS MARKET: DETAILED LIST OF KEY STARTUPS/SMES 201.
TABLE 216 VENTILATOR MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 202.
TABLE 217 VENTILATORS MARKET: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2026 205.
TABLE 218 VENTILATORS MARKET: DEALS, JANUARY 2021–JUNE 2026 206.
TABLE 219 VENTILATORS MARKET: OTHER DEVELOPMENTS, JANUARY 2021–JUNE 2026 208.
TABLE 220 DRÄGERWERK AG & CO. KGAA: COMPANY OVERVIEW 210.
TABLE 221 DRÄGERWERK AG & CO. KGAA: PRODUCTS OFFERED 211.
TABLE 222 DRÄGERWERK AG & CO. KGAA: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2026 212.
TABLE 223 DRÄGERWERK AG & CO. KGAA: DEALS, JANUARY 2021–JUNE 2026 212.
TABLE 224 DRÄGERWERK AG & CO. KGAA: OTHER DEVELOPMENTS, JANUARY 2021–JUNE 2026 213.
TABLE 225 GETINGE AB: COMPANY OVERVIEW 215.
TABLE 226 GETINGE AB: PRODUCTS OFFERED 216.
TABLE 227 GETINGE AB: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2026 217.
TABLE 228 GETINGE AB: DEALS, JANUARY 2021–JUNE 2026 217.
TABLE 229 GETINGE AB: OTHER DEVELOPMENTS, JANUARY 2021–JUNE 2026 217.
TABLE 230 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: COMPANY OVERVIEW 219.
TABLE 231 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: PRODUCTS OFFERED 220.
TABLE 232 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2026 221.
TABLE 233 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: OTHER DEVELOPMENTS, JANUARY 2021–JUNE 2026 221.
TABLE 234 ASAHI KASEI CORPORATION: COMPANY OVERVIEW 223.
TABLE 235 ASAHI KASEI CORPORATION: PRODUCTS OFFERED 224.
TABLE 236 ASAHI KASEI CORPORATION: DEALS, JANUARY 2021–JUNE 2026 225.
TABLE 237 RESMED INC.: COMPANY OVERVIEW 226.
TABLE 238 RESMED INC.: PRODUCTS OFFERED 227.
TABLE 239 RESMED INC.: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2026 228.
TABLE 240 RESMED INC.: DEALS, JANUARY 2021–JUNE 2026 228.
TABLE 241 RESMED INC.: OTHER DEVELOPMENTS, JANUARY 2021–JUNE 2026 228.
TABLE 242 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW 230.
TABLE 243 KONINKLIJKE PHILIPS N.V.: PRODUCTS OFFERED 231.
TABLE 244 KONINKLIJKE PHILIPS N.V.: OTHER DEVELOPMENTS, JANUARY 2021–JUNE 2026 232.
TABLE 245 ICU MEDICAL INC.: COMPANY OVERVIEW 234.
TABLE 246 ICU MEDICAL INC.: PRODUCTS OFFERED 235.
TABLE 247 ICU MEDICAL INC.: DEALS, JANUARY 2021–JUNE 2026 236.
TABLE 248 AIR LIQUIDE: COMPANY OVERVIEW 238.
TABLE 249 AIR LIQUIDE: PRODUCTS OFFERED 239.
TABLE 250 FLEXICARE (GROUP) LIMITED: COMPANY OVERVIEW 242.
TABLE 251 FLEXICARE (GROUP) LIMITED: PRODUCTS OFFERED 243.
TABLE 252 FLEXICARE (GROUP) LIMITED: DEALS, JANUARY 2021–JUNE 2026 243.
TABLE 253 NIHON KOHDEN CORPORATION: COMPANY OVERVIEW 244.
TABLE 254 NIHON KOHDEN CORPORATION: PRODUCTS OFFERED 245.
TABLE 255 NIHON KOHDEN CORPORATION: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2026 245.
TABLE 256 GE HEALTHCARE: COMPANY OVERVIEW 247.
TABLE 257 GE HEALTHCARE: PRODUCTS OFFERED 248.
TABLE 258 HAMILTON MEDICAL: COMPANY OVERVIEW 250.
TABLE 259 HAMILTON MEDICAL: PRODUCTS OFFERED 250.
TABLE 260 HAMILTON MEDICAL: PRODUCT UPGRADES, JANUARY 2021–JUNE 2026 250.
TABLE 261 HAMILTON MEDICAL: DEALS, JANUARY 2021–JUNE 2026 251.
TABLE 262 HAMILTON MEDICAL: OTHER DEVELOPMENTS, JANUARY 2021–JUNE 2026 251.
TABLE 263 RISK ASSESSMENT 284.
FIGURE 1 VENTILATORS MARKET SEGMENTATION & REGIONS COVERED 27.
FIGURE 2 KEY INSIGHTS & MARKET HIGHLIGHTS 31.
FIGURE 3 VENTILATORS MARKET, 2024–2031 32.
FIGURE 4 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN VENTILATORS MARKET 33.
FIGURE 5 DISRUPTIVE TRENDS IMPACTING GROWTH OF VENTILATORS MARKET 34.
FIGURE 6 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS IN VENTILATORS MARKET, 2026 35.
FIGURE 7 ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 36.
FIGURE 8 RISING PREVALENCE OF CHRONIC RESPIRATORY DISEASES TO DRIVE MARKET 37.
FIGURE 9 INTENSIVE CARE VENTILATORS SEGMENT ACCOUNTED FOR LARGEST SHARE IN 2025 38.
FIGURE 10 INDIA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 39.
FIGURE 11 NORTH AMERICA WILL DOMINATE MARKET TILL 2031 39.
FIGURE 12 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES OVER FORECAST PERIOD 40.
FIGURE 13 VENTILATORS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 41.
FIGURE 14 ANNUAL DEATHS CAUSED BY HOUSEHOLD AND AMBIENT AIR POLLUTION, BY DISEASE TYPE, 2024 43.
FIGURE 15 GLOBAL GERIATRIC POPULATION, BY COUNTRY, 2015 VS. 2020 VS. 2023 44.
FIGURE 16 VENTILATORS MARKET: PORTER’S FIVE FORCES ANALYSIS 54.
FIGURE 17 VENTILATORS MARKET: SUPPLY CHAIN ANALYSIS 60.
FIGURE 18 VENTILATORS MARKET: VALUE CHAIN ANALYSIS 61.
FIGURE 19 VENTILATORS MARKET: ECOSYSTEM ANALYSIS 62.
FIGURE 20 AVERAGE SELLING PRICE TREND OF HIGH-END VENTILATORS, BY REGION, 2023–2025 (USD) 64.
FIGURE 21 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 67.
FIGURE 22 VENTILATORS MARKET: INVESTMENT & FUNDING SCENARIO 68.
FIGURE 23 NUMBER OF PATENTS PUBLISHED (JANUARY 2016─JULY 2026) 77.
FIGURE 24 TOP APPLICANT COUNTRIES/REGIONS FOR VENTILATORS (JANUARY 2016− JULY 2026) 78.
FIGURE 25 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR VENTILATORS 88.
FIGURE 26 KEY BUYING CRITERIA FOR VENTILATORS 88.
FIGURE 27 NORTH AMERICA: VENTILATORS MARKET SNAPSHOT 128.
FIGURE 28 ASIA PACIFIC: VENTILATORS MARKET SNAPSHOT 155.
FIGURE 29 OVERVIEW OF STRATEGIES DEPLOYED BY KEY COMPANIES 188.
FIGURE 30 REVENUE ANALYSIS OF KEY PLAYERS OPERATING IN VENTILATORS MARKET, 2021–2025 189.
FIGURE 31 MARKET SHARE ANALYSIS OF KEY PLAYERS IN VENTILATORS MARKET, 2025 190.
FIGURE 32 VENTILATORS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025 192.
FIGURE 33 VENTILATORS MARKET: COMPANY FOOTPRINT 193.
FIGURE 34 VENTILATORS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025 200.
FIGURE 35 R&D EXPENDITURE OF KEY PLAYERS IN VENTILATORS MARKET (2024 VS. 2025) 202.
FIGURE 36 EV/EBITDA OF KEY VENDORS 203.
FIGURE 37 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 203.
FIGURE 38 BRAND/PRODUCT COMPARATIVE ANALYSIS 204.
FIGURE 39 DRÄGERWERK AG & CO. KGAA: COMPANY SNAPSHOT (2025) 211.
FIGURE 40 GETINGE AB: COMPANY SNAPSHOT (2025) 216.
FIGURE 41 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: COMPANY SNAPSHOT (2025) 220.
FIGURE 42 ASAHI KASEI CORPORATION: COMPANY SNAPSHOT (2025) 224.
FIGURE 43 RESMED INC.: COMPANY SNAPSHOT (2025) 227.
FIGURE 44 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2025) 231.
FIGURE 45 SMITHS GROUP PLC: COMPANY SNAPSHOT (2025) 235.
FIGURE 46 AIR LIQUIDE: COMPANY SNAPSHOT (2025) 239.
FIGURE 47 NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT (2025) 244.
FIGURE 48 GE HEALTHCARE: COMPANY SNAPSHOT (2025) 248.
FIGURE 49 RESEARCH DESIGN 270.
FIGURE 50 KEY DATA FROM SECONDARY SOURCES 272.
FIGURE 51 PRIMARY SOURCES 272.
FIGURE 52 KEY DATA FROM PRIMARY SOURCES 273.
FIGURE 53 KEY INDUSTRY INSIGHTS 274.
FIGURE 54 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE & DEMAND-SIDE PARTICIPANTS 274.
FIGURE 55 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION 275.
FIGURE 56 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY CARE SETTING, DESIGNATION, AND REGION 275.
FIGURE 57 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 276.
FIGURE 58 REVENUE SHARE ANALYSIS ILLUSTRATION: DRÄGERWERK AG & CO. KGAA (GERMANY) (2025) 277.
FIGURE 59 SUPPLY-SIDE MARKET SIZE ESTIMATION 278.
FIGURE 60 DEMAND-SIDE MARKET SIZE ESTIMATION 279.
FIGURE 61 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES FOR VENTILATORS MARKET (2026–2031) 280.
FIGURE 62 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 281.
FIGURE 63 TOP-DOWN APPROACH 282.
FIGURE 64 DATA TRIANGULATION METHODOLOGY 283.